Conventional radiotherapy delivers uniform doses, often causes collateral damage to nearby healthy tissues and thus limits tumor dose escalation. In clinic, a spatially modulated dose delivery technique, a.k.a., spatially fractionated radiation therapy (SFRT) has gained tremendous momentum in radiotherapy research frontier. Raycision has developed an SFRT device to enable spatial dose modulation by closely mimicking the clinical approaches.
Reliable SFRT technology requires integrating spatial dose modulation, real-time imaging, and precise beam delivery into one system. Key challenges include sub-millimeter beam accuracy, accurate tumor tracking, and reproducible dose delivery across complex anatomy. Raycison tackled all these challenges through the long-accumulated deep experiences. In addition, Raycision’s exclusive 3D molecular imaging capability and AI-driven treatment planning software dramatically simplifies the overall treatment workflow.
SFRT shifts radiotherapy from uniform dosing to spatially modulated precision delivery, with a great promise of further improving therapeutic ratio. Raycision’s SFRT technology can be used to explore the frontiers of radiobiology and radiotherapy research. We hope the preclinical disvoeries can eventually be translated from bench to bed side benefiting millions of cancer patients.
Raycision Empowers Research and Industry with Imaging and Radiation Solutions Tailored to Your Exact Needs.
